Cited by 2,621Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE

Miller, G.J, Miller, N.E·1975·The Lancet

DOI 10.1016/s0140-6736(75)92376-4

Open this paper in CoChat — free account

Abstract

The body cholesterol pool increases with decreasing plasma-high-density-lipoprotein (H.D.L.) but is unrelated to the plasma concentrations of total cholesterol and other lipoproteins. This finding supports existing evidence that H.D.L. facilitates the uptake of cholesterol from peripheral tissues and its transport to the liver for catabolism and excretion. Plasma-H.D.L., is reduced in several conditions associated with an increased risk of future ischaemic heart-disease (I.H.D.), namely hypercholesterolaemia, hypertriglyceridaimia, male sex, obesity, and diabetes mellitus, while subjects with existing clinical I.H.D. have lower levels of H.D.L. than healthy subjects within the same community. It is proposed that a reduction of plasma-H.D.L. concentration may accelerate the development of atherosclerosis, and hence I.H.D., by impairing the clearance of cholesterol from the arterial wall.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(75)92376-4

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91658-8 · Cited by 690
Protein-lipid relationships in human plasma
Barr, D. P., Russ, E. M., & Eder, H. A. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90183-0 · Cited by 635
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
Slack, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90930-1 · Cited by 625
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1986.tb07607.x · Cited by 604
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701192760305 · Cited by 526
VIGOROUS EXERCISE IN LEISURE-TIME AND THE INCIDENCE OF CORONARY HEART-DISEASE
Morris, J. N., Chave, S. P. W., Adam, C., Sirey, C., Epstein, L. H., & Sheehan, D. J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90128-1 · Cited by 456

Show all 59 references

Research works printed but not linked: 13

Miller, 1973, J. Lab. clin. Med., 82, 876
Goodman, 1973, J. Lipid Res., 52, 2646
Insull, 1968, J. Lab. clin. Med., 72, 885
Schreibman, 1973, Clin. Res., 21, 638
P. Clifton-Bligh, N.E. Miller, P.J. Nestel, Clin. Sci. ((in the press)).
Nikkilä, 1953, Scand. J. clin. Lab. Invest., 5
Fredrickson, 1968, J. clin. Invest., 47, 2446, 10.1172/JCI105927 · DOI
N.E. Miller, P.J. Nestel, Eur. J. clin. Invest. ((in the press)).
Kannel, 1962, Geriatrics, 17, 675
Murphy, 1962, J. Lab. clin. Med., 60, 86
Kudchodkar, 1972, Clin. Res., 20, 944
Jones, 1970, J. Lab. clin. Med., 75, 953
Bondjers, 1974, Proc. Eur. Soc. clin. Invest., 8, 123

Sorted by citations

Items 101–200 of 1,001

The Effect of Cessation and Resumption of Moderate Alcohol Intake on Serum High-Density-Lipoprotein Subfractions
Haskell, W. L., Camargo, C. A., Williams, P. T., VRANIZAN, K. M., Krauss, R. M., Lindgren, F. T., & Wood, P. D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403293101301 · Cited by 304
Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element
Claudel, T., Sturm, E., Duez, H., Pineda‐Torra, I., Sirvent, A., Kosykh, V., Fruchart, J., Dallongeville, J., Hum, D. W., Kuipers, F., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14505 · Cited by 301
Preferential Utilization of Free Cholesterol From High-Density Lipoproteins for Biliary Cholesterol Secretion in Man
Schwartz, C. C., Halloran, P. F., Vlahčevič, Z. R., Gregory, D. H., & Swell, L. (1978) · Science · doi:10.1126/science.204996 · Cited by 300
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins
Shah, P. K., Kaul, S., Nilsson, J. Å., & Cercek, B. (2001) · Circulation · doi:10.1161/hc4501.098468 · Cited by 298
Plasma triglyceride determines structure-composition in low and high density lipoproteins.
Deckelbaum, R. J., Granot, E., Oschry, Y., Rose, L., & Eisenberg, S. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.3.225 · Cited by 294
Common Genetic Variation in ABCA1 Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease
Clee, S. M., Zwinderman, A. H., Engert, J. C., van Spaendonck‐Zwarts, K. Y., Molhuizen, H. O. F., Roomp, K., Jukema, J. W., van Wijland, M. J. A., van Dam, M., Hudson, T. J., et al. (2001) · Circulation · doi:10.1161/01.cir.103.9.1198 · Cited by 291
The paraoxonase gene family and atherosclerosis
Ng, C. J., Shih, D. M., Hama, S. Y., Villa, N., Navab, M., & Reddy, S. T. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.035 · Cited by 290
Evidence for an independent relationship between insulin resistance and fasting plasma HDL‐cholesterol, triglyceride and insulin concentrations
Laws, A., & Reaven, G. M. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00494.x · Cited by 289
Regulation of Lipid and Lipoprotein Metabolism by PPAR Activators
Gervois, P., Torra, I. P., Fruchart, J.-C., & Staels, B. (2000) · cclm · doi:10.1515/cclm.2000.002 · Cited by 249
Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men. A randomized controlled trial.
Puddey, I. B., Beilin, L. J., Vandongen, R., Rouse, I. L., & Rogers, P. (1985) · Hypertension · doi:10.1161/01.hyp.7.5.707 · Cited by 287
Evidence of health benefits of canola oil
Lin, L., Allemekinders, H., Dansby, A., Campbell, L., Durance-Tod, S., Berger, A., & Jones, P. J. H. (2013) · Nutrition Reviews · doi:10.1111/nure.12033 · Cited by 285
High density lipoprotein distribution
Anderson, D. W., Nichols, A. V., Pan, S., & Lindgren, F. T. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90005-9 · Cited by 283
The Caerphilly and Speedwell Collaborative Heart Disease Studies
Miller, N. E., Bolton, C., Hayes, T. M., Bainton, D., YARNELL, J. W. G., Baker, I. A., & Sweetnam, P. M. (1992) · Cited by 282
Self-citation
The Plasma Lipoproteins
Osborne, J. C., & Brewer, H. B. (1977) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60220-x · Cited by 282
The effect of exercise on plasma high density lipoproteins
Wood, P. D., & Haskell, W. L. (1979) · Lipids · doi:10.1007/bf02533428 · Cited by 280
Estrogen Use and All-Cause Mortality
Bush, T. L. (1983) · JAMA · doi:10.1001/jama.1983.03330310033022 · Cited by 280
Lipid abnormalities in renal disease
Appel, G. B. (1991) · Kidney International · doi:10.1038/ki.1991.22 · Cited by 278
Diabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in east London.
McKeigue, P., Marmot, M. G., Court, Y. D. S., Cottier, D., Rahman, S., & Riemersma, R. A. (1988) · Heart · doi:10.1136/hrt.60.5.390 · Cited by 278
Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins
Borggreve, S. E., Vries, R. D., & Dullaart, R. P. F. (2003) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2003.01263.x · Cited by 277
Genetic Cholesteryl Ester Transfer Protein Deficiency Is Extremely Frequent in the Omagari Area of Japan: Marked Hyperalphalipoproteinemia Caused by CETP Gene Mutation Is Not Associated With Longevity
Hirano, K.-I., Yamashita, S., Nakajima, N., Arai, T., Maruyama, T., Yoshida, Y., Ishigami, M., Sakai, N., Kameda-Takemura, K., & Matsuzawa, Y. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1053 · Cited by 275
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies
Krishna, R., Anderson, M. S., Bergman, A. J., Jin, B., Fallon, M. S., Côté, J., Rosko, K., Chavez-Eng, C. M., Lutz, R., Bloomfield, D. M., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61813-3 · Cited by 275
A MECHANISM BY WHICH HIGH-DENSITY LIPOPROTEINS MAY SLOW THE ATHEROGENIC PROCESS
Carew, T., Hayes, S., Koschinsky, T., & Steinberg, D. H. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92650-7 · Cited by 270
Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
Brinton, E. A., Eisenberg, S., & Breslow, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.707 · Cited by 265
Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.
SNIDERMAN, A. D., WOLFSON, C., TENG, B., FRANKLIN, F. A., BACHORIK, P. S., & KWITEROVICH, P. O. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-6-833 · Cited by 266
A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins.
Silva, H. V. D., Stuart, W. D., Duvic, C. R., Wetterau, J. R., Ray, M. J., Ferguson, D. G., Albers, H. W., Smith, W. R., & Harmony, J. A. K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38290-0 · Cited by 265
Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial Hypercholesterolemia
Mabuchi, H., Haba, T., Tatami, R., Miyamoto, S., Sakai, Y., Wakasugi, T., Watanabe, A., Koizumi, J., & Takeda, R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108273050902 · Cited by 262
Endocrinology Alfresco: Psychoendocrine Studies of Wild Baboons
SAPOLSKY, R. M. (1993) · Recent Progress in Hormone Research · doi:10.1016/b978-0-12-571148-7.50020-8 · Cited by 258
High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.
Johansson, J., Carlson, L. A., Landou, C., & Hamsten, A. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.174 · Cited by 259
A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.
Brinton, E. A., Eisenberg, S., & Breslow, J. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114405 · Cited by 258
Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase.
Patsch, J. R., Prasad, S. C., Gotto, A. M., & Bengtsson-Olivecrona, G. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111624 · Cited by 256
Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.
Brinton, E. A., Eisenberg, S., & Breslow, J. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115028 · Cited by 255
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile
van der Valk, M., Kastelein, J. J. P., Murphy, R. L., van Leth, F., Katlama, C., Horban, A., Glesby, M. J., Behrens, G. M. N., Clotet, B., Stellato, R. K., et al. (2001) · AIDS · doi:10.1097/00002030-200112070-00008 · Cited by 251
Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism
Shepherd, J., Packard, C. J., Patsch, J. R., Gotto, A. M., & Taunton, O. D. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109385 · Cited by 248
Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function
Lee, J. M. S., Robson, M. D., Yu, L.-M., Shirodaria, C. C., Cunnington, C., Kylintireas, I., Digby, J. E., Bannister, T., Handa, A., Wiesmann, F., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.036 · Cited by 246
Elevation of Plasma High-Density Lipoprotein Concentration Reduces Interleukin-1–Induced Expression of E-Selectin in an In Vivo Model of Acute Inflammation
COCKERILL, G. W., Huehns, T. Y., Weerasinghe, A., Stocker, C. J., Lerch, P. G., Miller, N. E., & Haskard, D. O. (2001) · Circulation · doi:10.1161/01.cir.103.1.108 · Cited by 246
Self-citation
The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes.
Thompson, E. A., Deeb, S. S., Walker, D., & Motulsky, A. G. (1988) · PubMed · Cited by 246
Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.
Pedro‐Botet, J., Sentı́, M., Nogués, X., Rubiés-Prat, J., Roquer, J., D'Olhaberriague, L., & Olivé, J. (1992) · Stroke · doi:10.1161/01.str.23.11.1556 · Cited by 245
Cholesterol and Coronary Heart Disease
Grundy, S. M. (1990) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519009090537 · Cited by 242
Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.
Vu‐Dac, N., Schoonjans, K., Laine, B., Fruchart, J., Auwerx, J. H., & Staels, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47383-8 · Cited by 244
Relation of Diet to High-Density-Lipoprotein Cholesterol in Middle-Aged Marathon Runners, Joggers, and Inactive Men
Hartung, G. H., Foreyt, J. P., Mitchell, R. E., Vlasek, I. W., & Gotto, A. M. (1980) · New England Journal of Medicine · doi:10.1056/nejm198002143020701 · Cited by 240
Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy products
Fernandes, C. F., SHAHANI, K. M., & Amer, M. A. (1987) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1987.tb02471.x · Cited by 237
Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women
Jeppesen, J., Schaaf, P., Jones, C., Zhou, M., Chen, Y., & Reaven, G. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.4.1027 · Cited by 232
Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis.
Austin, M. A., King, M., VRANIZAN, K. M., Newman, B. M., & Krauss, R. M. (1988) · PubMed · Cited by 234
Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease.
Schaefer, E. J., Heaton, W. H., Wetzel, M. G., & Brewer, H. B. (1982) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.2.1.16 · Cited by 233
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men
Lamarche, B., Uffelman, K. D., Carpentier, A. C., Cohn, J. S., Steiner, G., Barrett, P. H. R., & Lewis, G. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5286 · Cited by 230
Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion
Brousseau, M. E., Diffenderfer, M. R., Millar, J. S., Nartsupha, C., Asztalos, B. F., Welty, F. K., Wolfe, M. L., Rudling, M. J., Björkhem, I., Angelin, B., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000161928.16334.dd · Cited by 230
The role of hepatic lipase in lipoprotein metabolism and atherosclerosis
Santamarina-Fojo, S., Haudenschild, C., & Amar, M. J. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00005 · Cited by 229
Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk
Chapman, M. J., Redfern, J. S., McGovern, M. E., & Giral, P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.008 · Cited by 227
Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.
McElveen, J. E., Mackness, M., COLLEY, C. M., Peard, T., Warner, S., & Walker, C. H. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.4.671 · Cited by 227
Lipid abnormalities in uremia, dialysis, and transplantation
Chan, M. K., Varghese, Z., & Moorhead, J. F. (1981) · Kidney International · doi:10.1038/ki.1981.62 · Cited by 227
Apolipoprotein L, a New Human High Density Lipoprotein Apolipoprotein Expressed by the Pancreas
Duchateau, P. N., Pullinger, C. R., Orellana, R. E., Kunitake, S. T., Naya-Vigne, J. M., O'Connor, P. M., Malloy, M. J., & Kane, J. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25576 · Cited by 226
Translation of High-Density Lipoprotein Function Into Clinical Practice
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P. J., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2013) · Circulation · doi:10.1161/circulationaha.113.000962 · Cited by 225
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins
Shah, P. K., Kaul, S., Nilsson, J. Å., & Cercek, B. (2001) · Circulation · doi:10.1161/hc4401.098467 · Cited by 223
Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland
Tuomilehto, J. O., Borch‐Johnsen, K., Molarius, A., Forsén, T., Rastenytė, D., Sarti, C., & Reunanen, A. (1998) · Diabetologia · doi:10.1007/s001250050988 · Cited by 222
SERUM-HIGH-DENSITY-LIPOPROTEIN AND ATHEROSCLEROTIC HEART-DISEASE
Berg, K., Børresen‐Dale, A., & Dahlén, G. H. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90291-9 · Cited by 222
Coronary Heart Disease Prevalence and Other Clinical Features in Familial High-Density Lipoprotein Deficiency (Tangier Disease)
Schaefer, E. J., ZECH, L. A., SCHWARTZ, D. E., & BREWER, H. B. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-2-261 · Cited by 220
Human Apolipoprotein A-I and A-II Metabolism
Brewer, H. B., Gregg, R. E., Law, S. W. T., Hoeg, J. M., & Zech, L. A. (1987) · Proceedings in life sciences · doi:10.1007/978-3-642-71702-4_44 · Cited by 218
Serum lipoprotein profile in children from a biracial community: the Bogalusa Heart Study.
Srinivasan, S. R., Frerichs, R. R., Webber, L. S., & Berenson, G. S. (1976) · Circulation · doi:10.1161/01.cir.54.2.309 · Cited by 217
Metabolic Fate of Chylomicron Phospholipids and Apoproteins in the Rat
Tall, A. R., Green, P. H. R., Glickman, R. M., & Riley, J. W. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109564 · Cited by 217
Serum cholesterol and triglyceride levels in 3,446 children from a biracial community: the Bogalusa Heart Study.
Frerichs, R. R., Srinivasan, S. R., Webber, L. S., & Berenson, G. (1976) · Circulation · doi:10.1161/01.cir.54.2.302 · Cited by 216
Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man
Nikkilä, E. A., Taskinen, M.-R., & Kekki, M. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90178-8 · Cited by 160
Effects of a vigorous walking program on body composition, and carbohydrate and lipid metabolism of obese young men
Leon, A. S., Conrad, J., Db, H., & SERFASS, R. C. (1979) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.9.1776 · Cited by 213
Pathogenesis and Management of Lipoprotein Disorders
Flier, J. S., Underhill, L. H., Schaefer, E. J., & Levy, R. I. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505163122007 · Cited by 213
Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men: The Caerphilly and Speedwell Collaborative Heart Disease Studies
Bainton, D., Miller, N., Bolton, C., YARNELL, J. W. G., Sweetnam, P. M., Baker, I. A., Lewis, B., & Elwood, P. C. (1992) · Heart · doi:10.1136/hrt.68.7.60 · Cited by 210
Self-citation
The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects
Schaefer, E. J., Levy, R. I., Ernst, N. D., Sant, F. D. V., & Brewer, H. B. (1981) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.9.1758 · Cited by 209
Comparison of Class B Scavenger Receptors, CD36 and Scavenger Receptor BI (SR-BI), Shows That Both Receptors Mediate High Density Lipoprotein-Cholesteryl Ester Selective Uptake but SR-BI Exhibits a Unique Enhancement of Cholesteryl Ester Uptake
Connelly, M. A., Klein, S. M., Azhar, S., Abumrad, N. A., & Williams, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.41 · Cited by 208
Obesity, lipids, and glucose intolerance The Framingham Study
Kannel, W. B., Gordon, T., & Castelli, W. P. (1979) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.6.1238 · Cited by 207
Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit
Miller, N. E., Ville, A. L., & Crook, D. (1985) · Nature · doi:10.1038/314109a0 · Cited by 207
Self-citation
Human apolipoprotein A-I and A-II metabolism
Schaefer, E. J., Zech, L. A., Jenkins, L. L., Bronzert, T. J., Rubalcaba, E. A., Lindgren, F. T., Aamodt, R. L., & Brewer, H. B. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38087-1 · Cited by 207
Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.
Tobert, J. A., Bell, G. D., Birtwell, J., James, I. M., Kukovetz, W. R., Pryor, J., Buntinx, A., Holmes, I. B., Chao, Y. S., & Bolognese, J. A. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110530 · Cited by 204
Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients With Type 2 Diabetes
Patel, S., Drew, B. G., Nakhla, S., Duffy, S. J., Murphy, A. J., Barter, P. J., Rye, K., Chin-Dusting, J. P. F., Hoang, A., Sviridov, D., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.008 · Cited by 203
Apolipoprotein A-I Gene Polymorphism Associated with Premature Coronary Artery Disease and Familial Hypoalphalipoproteinemia
Ordovás, J. M., Schaefer, E. J., Salem, D. N., Ward, R. H., Glueck, C. J., Vergani, C., Wilson, P. W. F., & Karathanasis, S. K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603133141102 · Cited by 203
Fasting Hypertriglyceridemia in Non insulin-Dependent Diabetes Mellitus Is an Important Predictor of Postprandial Lipid and Lipoprotein Abnormalities*
Lewis, G. F., O’Meara, N., Soltys, P. A., Blackman, J. D., Iverius, P., Pugh, W. L., Getz, G. S., & Polonsky, K. S. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-4-934 · Cited by 201
Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.
Yui, Y., Aoyama, T., Morishita, H., Takahashi, M., Takatsu, Y., & Kawai, C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113682 · Cited by 200
High-Density Lipoproteins in Sepsis and Septic Shock: Metabolism, Actions, and Therapeutic Applications
Wu, A., Hinds, C., & Thiemermann, C. (2004) · Shock · doi:10.1097/01.shk.0000111661.09279.82 · Cited by 203
Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux
Calkin, A. C., Drew, B. G., Ono, A., Duffy, S. J., Gordon, M. V., Schoenwaelder, S. M., Sviridov, D., Cooper, M. E., Kingwell, B. A., & Jackson, S. P. (2009) · Circulation · doi:10.1161/circulationaha.109.870709 · Cited by 198
High density lipoproteins (HDL) and physical activity: the influence of physical exercise, age and smoking on HDL-cholesterol and the HDL-/total cholesterol ratio
Enger, S. C., Herbjørnsen, K., Erikssen, J., & Fretland, A. (1977) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517709091490 · Cited by 197
Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study
van Dam, M., de Groot, E., Clee, S. M., Hovingh, G. K., Roelants, R. J., Brooks-Wilson, A., Zwinderman, A. H., Smit, A. J., Smelt, A. H. M., Groen, A. K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07277-x · Cited by 196
PLASMA-TRIGLYCERIDES IN REGULATION OF H.D.L.-CHOLESTEROL LEVELS
Schaefer, E. J., Anderson, D. W., Brewer, H. B., Levy, R. I., Danner, R., & Blackwelder, W. C. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91863-9 · Cited by 196
Relation Among the Plasma Triglyceride/High-Density Lipoprotein Cholesterol Concentration Ratio, Insulin Resistance, and Associated Cardio-Metabolic Risk Factors in Men and Women
Salazar, M. R., Carbajal, H. A., Espeche, W. G., Sisnieguez, C. E. L., Balbín, E., Dulbecco, C. A., Aizpurúa, M., Marillet, A. G., & Reaven, G. M. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.02.016 · Cited by 195
HDL-mediated mechanisms of protection in cardiovascular disease
Kontush, A. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu147 · Cited by 198
Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells
Jin, F.-Y., Kamanna, V. S., & Kashyap, M. L. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2020 · Cited by 194
How high-density lipoprotein protects against the effects of lipid peroxidation
Mackness, M., Durrington, P. N., & Mackness, B. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200008000-00007 · Cited by 193
Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
Hamsten, A., Walldius, G., Szamosi, A., Dahlén, G., & Fairé, U. D. (1986) · Circulation · doi:10.1161/01.cir.73.6.1097 · Cited by 192
Common Variants in the Promoter of the Hepatic Lipase Gene Are Associated With Lower Levels of Hepatic Lipase Activity, Buoyant LDL, and Higher HDL2Cholesterol
Zambon, A., Deeb, S. S., Hokanson, J. E., Brown, B. G., & Brunzell, J. D. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1723 · Cited by 192
Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits
Miyazaki, A., Sakuma, S., Morikawa, W., Takiue, T., Miake, F., Terano, T., Sakai, M., Hakamata, H., Sakamoto, Y.-I., Naito, M., et al. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1882 · Cited by 190
Inhibition of cholesterol and fatty acid biosynthesis in liver enzymes and chicken hepatocytes by polar fractions of garlic,
Qureshi, A. A., Abuirmeileh, N. M., Din, Z. Z., Elson, C. E., & Burger, W. C. (1983) · Lipids · doi:10.1007/bf02537229 · Cited by 189
Powerful three-sample genome-wide design and robust statistical inference in summary-data Mendelian randomization.
Zhao, Q., Chen, Y., Wang, J., & Small, D. S. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz142 · Cited by 188
Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men
Riales, R. R., & Albrink, M. J. (1981) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.12.2670 · Cited by 188
The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review
Dawson, S. J., & HENNEY, A. M. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90014-8 · Cited by 187
Pathogenesis and Management of Lipoprotein Disorders
Fredman, S. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603273141310 · Cited by 187
HIGH-DENSITY LIPOPROTEIN AND CORONARY RISK FACTORS IN NORMAL MEN
Williams, P., Robinson, D., & Bailey, A. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90063-1 · Cited by 186
Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.
Yamashita, S., Sprecher, D. L., Sakai, N., Matsuzawa, Y., Tarui, S., & Hui, D. Y. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114764 · Cited by 183
Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.
Shoji, T., Nishizawa, Y., Kawagishi, T., Kawasaki, K., Taniwaki, H., Tabata, T., Inoue, T., & Morii, H. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v971277 · Cited by 183
Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11
Ordovás, J. M., Cassidy, D. K., Civeira, F., Bisgaier, C. L., & Schaefer, E. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84708-7 · Cited by 182
Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant Patients
Bagdade, J. D., & Albers, J. J. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706232962504 · Cited by 182
Effects of Garlic on Lipid Metabolism in Rats Fed Cholesterol or Lard
Chi, M. S., Koh, E. T., & Stewart, T. J. (1982) · Journal of Nutrition · doi:10.1093/jn/112.2.241 · Cited by 179
Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease
Reaven, G. M., & Laws, A. (1994) · Diabetologia · doi:10.1007/bf00400953 · Cited by 180
Prevalence of serum lipid abnormalities in chronic hemodialysis
Brunzell, J. D., Albers, J. J., Haas, L. B., Goldberg, A. P., Agadoa, L., & Sherrard, D. J. (1977) · Metabolism · doi:10.1016/0026-0495(77)90009-9 · Cited by 179
Plasma apolipoprotein B and VLDL-, LDL-, and HDL- cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography
Whayne, T. F., Alaupovic, P., Curry, M. D., Lee, E. T., Anderson, P. S., & Schechter, E. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90026-5 · Cited by 179

Authors: Miller, G. J., & Miller, N. E.
Affiliations: University Hospital Llandough (GB)
Edinburgh Royal Infirmary (GB)
ORCID: Miller, G.J
Venue: The Lancet
Publisher: Elsevier BV
Published: 1975-01
Volume: 305
Issue: 7897
Pages: 16-19
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(75)92376-4
OpenAlex: W1994967652
Cited by: 2,621
References: 59
Citations by year: 2026: 5 · 2025: 11 · 2024: 9 · 2023: 7 · 2022: 15 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 18 · 2017: 17 · 2016: 29 · 2015: 29 · 2014: 22 · 2013: 32 · 2012: 26
FWCI: 157.87
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: high-density lipoprotein, ischemic heart disease, atherosclerosis, cholesterol metabolism, hypercholesterolemia, hypertriglyceridemia, obesity, diabetes mellitus, sex differences, cardiovascular risk factors
MeSH terms: Arteries, Arteriosclerosis, Cholesterol, Coronary Disease, Denmark, Inuit, Female, Finland, Humans, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Liver, Male, Middle Aged, Sex Factors, Sweden, Triglycerides, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks